Loading
Biorem Inc. Stock: price and insider trades · Canada
CA·Mcap CA$60.3M
Biorem Inc.: what insiders have been doing
Every trade that managers of Biorem Inc. disclose to SEDI is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 20 filings came from 3 insiders.
Only sales appear on the open market, 8 sales in all totalling €182k, filed by 2 insiders. Biggest ticket of the year: €68k, sold by Webb, Derek and made public on 27 August 2026 (0.18% of market cap).
Between a trade and the moment it shows up on SEDI, the median delay is 6 days. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 2,121 companies) published 11 filings over the same period, against 20 filings here. Looking back to 2026, when coverage begins, insiders filed no purchases and 8 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
20
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€182,152
8 ops. · all time
Who traded when
BuySaleDouglas Newman5 sales
Derek Webb3 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,062 of 24,148 companies
75.1
score / 100
Value76
Quality74
FCF yld12%
Earn yld8.0%
EV/EBITDA9.1x
ROE44%
Gross mgn30%
Net mgn11%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$3.72
Analyst consensus
1 analysts2.00/5
CA$4.50Target CA$4.50(+21%)CA$4.50
Income statement
RevenueCA$42.4M
Gross profitCA$12.8M30% margin
EBITDACA$7M16% margin
Net incomeCA$4.8M12.3% margin
Valuation
PER (trailing)11.3x
P/Book3.4x
Beta1.04
Balance sheet & cash
Market capCA$60.3M
Total debtCA$2.8M
Free Cash FlowCA$7.3M
Debt / Equity14%
Profitability & ownership
ROE43.6%
ROA16.6%
% insiders9.3%
% institutions0.1%
Last declaration on 1 October 2026
Declarations20 total
1,158,328 shares@ CA$0.3450.73% mcap37.5% of flowCommon SharesTSXSEDI:4783420
1,290,000 shares@ CA$0.3450.82% mcap41.7% of flowOptionsTSXSEDI:4783413
300,000 shares@ CA$0.3450.19% mcap33.4% of flowOptionsTSXSEDI:4783394
10,800 shares@ CA$3.400.060% mcap35.8% of flowCommon SharesTSXSEDI:4782189
4,200 shares@ CA$3.410.023% mcap14.0% of flowCommon SharesTSXSEDI:4782187
10,700 shares@ CA$3.430.060% mcap35.8% of flowCommon SharesTSXSEDI:4782186
3,800 shares@ CA$3.460.021% mcap12.8% of flowCommon SharesTSXSEDI:4782185
500 shares@ CA$3.470.0028% mcap1.7% of flowCommon SharesTSXSEDI:4782184
28,700 shares@ CA$3.820.18% mcap49.3% of flowCommon SharesTSXSEDI:4769232
6,300 shares@ CA$3.820.039% mcap10.9% of flowCommon SharesTSXSEDI:4769017
15,000 shares@ CA$3.82460.093% mcap25.9% of flowCommon SharesTSXSEDI:4767851
300 sharesCommon SharesTSXSEDI:4743180
300 shares@ CA$3.042.3% of flowCommon SharesTSXSEDI:4743177
10,700 sharesCommon SharesTSXSEDI:4743175
10,700 shares@ CA$3.0482.9% of flowCommon SharesTSXSEDI:4743171
900 sharesCommon SharesTSXSEDI:4743170
900 shares@ CA$3.047.0% of flowCommon SharesTSXSEDI:4743167
1,000 sharesCommon SharesTSXSEDI:4743164
1,000 shares@ CA$3.047.8% of flowCommon SharesTSXSEDI:4743162
90,000 shares@ CA$0.3450.050% mcap14.0% of flowOptionsTSXSEDI:4743092
20 of 20 declarations
About Biorem Inc.
Biorem Inc. is a company specializing in wastewater and gas treatment technologies. It is listed on the XTSE market.
